Erythropoietin Completed Phase 4 Trials for Chronic Renal Failure (CRF) / Anemias Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00338000EPO-BUL-01 - Study of the Optimization of Anemia Management of EPREX (Epoetin Alfa) in Predialysis Patients With Chronic Renal Failure
NCT01111630Study of Erythropoietin (EPO) Administration Schedule
NCT00776425A Study of the Quality of Life and Treatment Response to Once Weekly Epoetin Beta (Recormon) Treatment in Anemic Participants With Solid and Lymphoid Malignancies
NCT00377481COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
NCT00413101A Study of NeoRecormon (Epoetin Beta) in Patients With End Stage Renal Disease.
NCT00437723A Study of NeoRecormon in Patients With Chronic Kidney Disease.
NCT00401869The Effect of PROCRIT (Epoetin Alfa) on Postoperative Vigor and Handgrip Strength (VIGOR Study)
NCT00560274A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.
NCT02554942A Study of Epoetin Beta (NeoRecormon) in Participants With Solid Tumors
NCT02564094A Study of Epoetin Beta (NeoRecormon) in Participants With Solid Tumors or Hematologic Malignancies
NCT02569515A Study of Epoetin Beta (NeoRecormon) in Predialysis Patients With Renal Anemia